Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Behandling med intravenöst immunoglobulin vid neurologiska sjukdomar. Deskriptiv studie av effekter ur patientens och sjukvårdens perspektiv

Wintzell, Anne ; Eriksson, Tommy LU ; Lundgren, Anders LU and Petersson, Jesper LU (2008) In Läkartidningen 105(21). p.1571-1575
Abstract
We studied medical records for out-patient treatments with intravenous immunoglobulins during 2005 at the neurological clinics in Skåne and evaluated patient opinions using a questionnaire. Of 64 patients, 10 had started their therapy during the period, and 14 had it terminated. In five medical records doctor had defined and documented a therapy objective at the start of therapy and in six cases there was no concordance between the physician and patient about the risk-benefit of the therapy and its continuation. In five cases the physician expressed that there were difficulties to evaluate the effect. Patients were able to mention symptoms that bothered most before starting treatment. Of all patients 70% had few symptoms left, 46% had at... (More)
We studied medical records for out-patient treatments with intravenous immunoglobulins during 2005 at the neurological clinics in Skåne and evaluated patient opinions using a questionnaire. Of 64 patients, 10 had started their therapy during the period, and 14 had it terminated. In five medical records doctor had defined and documented a therapy objective at the start of therapy and in six cases there was no concordance between the physician and patient about the risk-benefit of the therapy and its continuation. In five cases the physician expressed that there were difficulties to evaluate the effect. Patients were able to mention symptoms that bothered most before starting treatment. Of all patients 70% had few symptoms left, 46% had at least moderate inconveniences and 88% considered their treatment important not to get worse. We conclude that intravenous immunoglobulin therapy effect is sometimes difficult to evaluate and communicate. Follow-up including treatment objectives could be helpful. (Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Läkartidningen
volume
105
issue
21
pages
1571 - 1575
publisher
Swedish Medical Association
external identifiers
  • pmid:18574994
  • scopus:45849145103
ISSN
0023-7205
language
Swedish
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Clinic of Neurology: University Hospital, Lund (LUR000008), Division IV (013230800), Department of Clinical Sciences, Lund (013230000)
id
9d4bc52e-307b-4abe-8881-d96e7d824eb7 (old id 1168508)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/18574994?dopt=Abstract
http://ltarkiv.lakartidningen.se/artNo35078
date added to LUP
2016-04-04 09:14:21
date last changed
2022-01-29 08:55:24
@article{9d4bc52e-307b-4abe-8881-d96e7d824eb7,
  abstract     = {{We studied medical records for out-patient treatments with intravenous immunoglobulins during 2005 at the neurological clinics in Skåne and evaluated patient opinions using a questionnaire. Of 64 patients, 10 had started their therapy during the period, and 14 had it terminated. In five medical records doctor had defined and documented a therapy objective at the start of therapy and in six cases there was no concordance between the physician and patient about the risk-benefit of the therapy and its continuation. In five cases the physician expressed that there were difficulties to evaluate the effect. Patients were able to mention symptoms that bothered most before starting treatment. Of all patients 70% had few symptoms left, 46% had at least moderate inconveniences and 88% considered their treatment important not to get worse. We conclude that intravenous immunoglobulin therapy effect is sometimes difficult to evaluate and communicate. Follow-up including treatment objectives could be helpful.}},
  author       = {{Wintzell, Anne and Eriksson, Tommy and Lundgren, Anders and Petersson, Jesper}},
  issn         = {{0023-7205}},
  language     = {{swe}},
  number       = {{21}},
  pages        = {{1571--1575}},
  publisher    = {{Swedish Medical Association}},
  series       = {{Läkartidningen}},
  title        = {{Behandling med intravenöst immunoglobulin vid neurologiska sjukdomar. Deskriptiv studie av effekter ur patientens och sjukvårdens perspektiv}},
  url          = {{http://www.ncbi.nlm.nih.gov/pubmed/18574994?dopt=Abstract}},
  volume       = {{105}},
  year         = {{2008}},
}